Tag: Disease
Precision For Medicine, Oncology and Rare Disease Named Best Specialist CRO By OBN Awards

Precision For Medicine, Oncology and Rare Disease Named Best Specialist CRO By OBN Awards

Precision's Unique Combination Of Clinical Services And Translational Sciences Is Recognised For Biotech Industry Innovation LONDON, Dec. 5, 2019 /PRNewswire/ -- Precision for ...

Lees verder
Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease

Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease

-- Oligomannate , A New Oral Treatment For Mild To Moderate Alzheimer's Disease -- The Only Approved Novel AD Treatment Globally Since 2003 SHANGHAI, Nov. 2, 2019 ...

Lees verder
Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community

Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community

- New open-label extension data from the Phase 2 OASIS trial for etrasimod in ulcerative colitis - Arena sponsored breakfast symposium: Will oral therapies change the IBD ...

Lees verder
AAIC® 2019 Highlights New Research Showing Healthy Lifestyle May Offset Environmental and Genetic Risk of Alzheimer's Disease

AAIC® 2019 Highlights New Research Showing Healthy Lifestyle May Offset Environmental and Genetic Risk of Alzheimer's Disease

International Conference Also Included Expert Discussion on Role of Infectious Agents in Alzheimer's Disease, and Advances Towards a Blood Test LOS ANGELES, July 17, 2019 ...

Lees verder
Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias

Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2019 LOS ANGELES, July 15, 2019 /PRNewswire/ -- Significant advances in the global search for blood test technologies ...

Lees verder
TAU BIO-LOGIC Announces Humanization of Picomolar Affinity Monoclonal Antibody Targeting TauC3 Protein for the Treatment of Alzheimer's Disease a

TAU BIO-LOGIC Announces Humanization of Picomolar Affinity Monoclonal Antibody Targeting TauC3 Protein for the Treatment of Alzheimer's Disease a

NEW YORK and LONDON, April 18, 2019 /PRNewswire/ -- TAU BIO-LOGIC CORP. announced today that in collaboration with the UK-based group LifeArc, it has successfully humanized a ...

Lees verder
European Heart Valve Disease Awareness Day 2018: New Data Indicates Low Awareness of Heart Valve Disease May Prevent Elderly People from Seeking

European Heart Valve Disease Awareness Day 2018: New Data Indicates Low Awareness of Heart Valve Disease May Prevent Elderly People from Seeking

LONDON, September 6, 2018 /PRNewswire/ -- - The call for improved education and diagnosis of heart valve disease comes following the results of a new survey ...

Lees verder
UCB Announces Approval of NEUPRO® in China to Treat Parkinson's Disease

UCB Announces Approval of NEUPRO® in China to Treat Parkinson's Disease

BRUSSELS, July 2, 2018 /PRNewswire/ -- - NEUPRO now approved in China for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's ...

Lees verder
Global Batten Community Unites To Launch Inaugural International Batten Disease (NCL) Awareness Day

Global Batten Community Unites To Launch Inaugural International Batten Disease (NCL) Awareness Day

Global Campaign Leverages Social Media to Build Awareness of Rare, Fatal Childhood Disease "Come Together" Enables People Worldwide to #MakeYourMark on Batten Disease ...

Lees verder
Norgine and Its Partner Salix Present New Data From PLENVU® (NER1006) Phase 3 Studies at Digestive Disease Week (DDW) 2018

Norgine and Its Partner Salix Present New Data From PLENVU® (NER1006) Phase 3 Studies at Digestive Disease Week (DDW) 2018

AMSTERDAM, June 5, 2018 /PRNewswire/ -- Norgine B.V. today with its partner Salix Pharmaceuticals, Ltd. ("Salix"), announced that they will present new data from phase 3 ...

Lees verder
BizPress.nl